ArticleFrontiers in immunology2022

TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome.

Stefania C Carrara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.